93
Participants
Start Date
January 10, 2018
Primary Completion Date
April 30, 2022
Study Completion Date
April 30, 2022
University of Calgary /ID# 166416, Calgary
Cross Cancer Institute /ID# 166417, Edmonton
Jack Ady Cancer Centre /ID# 217491, Lethbridge
CancerCare Manitoba /ID# 170751, Winnipeg
The Moncton Hospital /ID# 166043, Moncton
QE II Health Sciences Centre /ID# 213548, Halifax
William Osler Health System /ID# 202049, Brampton
Health Sciences North /ID# 205817, Greater Sudbury
Kingston Health Sciences Centre /ID# 169252, Kingston
Ottawa Hospital Research Institute /ID# 166041, Ottawa
Thunder Bay Regional Research Institute /ID# 204740, Thunder Bay
Jewish General Hospital /ID# 166418, Montreal
CISSSBSL -Hopital regional de Rimouski /ID# 201202, Rimouski
Lead Sponsor
AbbVie
INDUSTRY